Low doses (75-100 mg per day) of aspirin were found to be ineffective for people above 154 pounds, while higher doses only reduced cardiovascular events among patients with greater body size.

A retrospective study published July 13 in JAMA Network Open suggests placement of an inferior vena cava (IVC) filter is associated with an increased risk of 30-day mortality for patients with venous thromboembolic disease and a contraindication to anticoagulants.

A new study published in the Journal of the American Heart Association suggests greater adherence to a Southern (U.S.) diet is associated with a 56 percent increased risk of coronary heart disease (CHD) when compared to those with a Mediterranean diet.

The FDA on Friday, July 13, joined more than 20 other countries in recalling medications containing valsartan, an active ingredient used to treat hypertension and heart failure. Some of the medications with valsartan have been contaminated with N-nitrosodimethylamine (NDMA), a probable human carcinogen.

Women and black patients have higher coronary artery bypass grafting (CABG) mortality rates than men and white patients, according to new research published in the Journal of the American Heart Association.

The average blood pressure of American youths is declining, a new CDC report suggests, even as updated guidelines classify almost 800,000 more of them as hypertensive.

A new study, published July 11 in the Journal of the American Medical Association, suggests heart failure (HF) may be moderately hereditary.

A tuberculosis vaccine that has been around for a century is being investigated as a potential low-cost, long-term treatment for type 1 diabetes.